DPP-IV inhibitors, by virtue of their mechanism of action, increase the bioavailability of GLP-1 and GIP, leading to enhanced insulin secretion, improved glycemic control, and reduced insulin resistance in diabetes
Semaglutide and Tirzepatide both reduce appetite and slow digestion, helping with weight loss
miR-16 and miR-223 are also identified as targets to distinguish patients with early RA from healthy individuals ( Most of the aberrant miRNA levels can alter the secretion of inflammatory cytokines or MMPs, further affecting the procession of RA
The NO level of each group was normalized to its total protein
Understanding secondary injury
Because it takes time to increase glutathione production through diet, it can take months to feel the benefits